Body composition in psychotic disorders: A general population survey

Psychological Medicine

Volumn 39, Issue 5, 2009, Pages 801-810

  Saarni, S E ^a,b   Saarni, S I ^a   Fogelholm, M ^c,d   Heliovaara M ^a   Perala J ^a   Suvisaari, J ^a   Lonnqvist J ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^d PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Abdominal obesity; Bioimpedance; Mental disorder; Obesity; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ABDOMINAL OBESITY; ADULT; AFFECTIVE PSYCHOSIS; AGE DISTRIBUTION; ANTHROPOMETRY; ARM; ARTICLE; BIPOLAR I DISORDER; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRIEF PSYCHOTIC DISORDER; CARDIOVASCULAR DISEASE; CONSENSUS; DELUSIONAL DISORDER; DIET; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FINLAND; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; METABOLIC DISORDER; MUSCLE MASS; OBESITY; POPULATION RESEARCH; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REGISTER; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEX DIFFERENCE; SMOKING; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TRUNK; WAIST CIRCUMFERENCE; AGED; MIDDLE AGED; REFERENCE VALUE; RISK; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PSYCHOTIC DISORDERS; REFERENCE VALUES; SCHIZOPHRENIA; WAIST-HIP RATIO;

EID: 66849104093     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291708004194     Document Type: Article

References (59)

1. Ader M, Kim SP, Catalano KJ, Ionut V, Hucking K, Richey JM, Kabir M, Bergman RN (2005). Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54, 862-871. (Pubitemid 40322092)
2. Alexandersen P, Tanko LB, Bagger YZ, Jespersen J, Skouby SO, Christiansen C (2006). Associations between aortic calcification and components of body composition in elderly men. Obesity 14, 1571-1578. (Pubitemid 46214824)
3. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ (1999). Antipsychotic-induced weight gain: a comprehensive research synthesis. American Journal of Psychiatry 156, 1686-1696. (Pubitemid 29517559)
4. Amani R (2007). Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry 2, 15.
5. Anonymous (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 285, 2486-2497.
6. Anonymous (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596-601.
7. Bergman RN, Ader M (2005). Atypical antipsychotics and glucose homeostasis. Journal of Clinical Psychiatry 66, 504-514.
8. Bigaard J, Frederiksen K, Tjonneland A, Thomsen BL, Overvad K, Heitmann BL, Sorensen TI (2005). Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. International Journal of Obesity 29, 778-784. (Pubitemid 40897014)
9. Bigaard J, Tjonneland A, Thomsen BL, Overvad K, Heitmann BL, Sorensen TI (2003). Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obesity Research 11, 895-903. (Pubitemid 41137528)
10. Björntorp P, Rosmond R (2000). Obesity and cortisol. Nutrition 16, 924-936.
11. Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J (2007). Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophrenia Research 90, 162-173. (Pubitemid 46177553)
12. Brown S, Birtwistle J, Roe L, Thompson C (1999). The unhealthy lifestyle of people with schizophrenia. Psychological Medicine 29, 697-701.
13. Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G (2004). Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Canadian Journal of Psychiatry 49, 753-760.
14. Correll CU, Frederickson AM, Kane JM, Manu P (2006). Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. Journal of Clinical Psychiatry 67, 575-583. (Pubitemid 43764234)
15. De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J (2006). Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophrenia Research 83, 87-93.
16. Dickerson FB, Brown CH, Kreyenbuhl JA, Fang L, Goldberg RW, Wohlheiter K, Dixon LB (2006). Obesity among individuals with serious mental illness. Acta Psychiatrica Scandinavica 113, 306-313.
17. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ (2005). Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disorders 7, 424-430. (Pubitemid 41419409)
18. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002). Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 288, 1723-1727.
19. Fogelholm M, van Marken Lichtenbelt W (1997). Comparison of body composition methods: a literature analysis. European Journal of Clinical Nutrition 51, 495-503. (Pubitemid 27379801)
20. Goldbacher EM, Matthews KA (2007). Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Annals of Behavioral Medicine 34, 240-252.
21. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB (2006). Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine 354, 2552-2563. (Pubitemid 43882351)
22. Hägg S, Lindblom Y, Mjörndal T, Adolfsson R (2006). High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. International Clinical Psychopharmacology 21, 93-98. (Pubitemid 43740316)
23. Hakko H, Komulainen MT, Koponen H, Saari K, Laitinen J, Jarvelin MR, Lindeman S (2006). Are females at special risk of obesity if they become psychotic? The longitudinal Northern Finland 1966 Birth Cohort Study. Schizophrenia Research 84, 15-19.
24. Heilä H, Haukka J, Suvisaari J, Lönnqvist J (2005). Mortality among patients with schizophrenia and reduced psychiatric hospital care. Psychological Medicine 35, 725-732. (Pubitemid 40716436)
25. Heiskanen T, Niskanen L, Lyytikäinen R, Saarinen PI, Hintikka J (2003). Metabolic syndrome in patients with schizophrenia. Journal of Clinical Psychiatry 64, 575-579.
26. Heitmann BL (1994). Impedance: a valid method in assessment of body composition? European Journal of Clinical Nutrition 48, 228-240.
27. Homel P, Casey D, Allison DB (2002). Changes in body mass index for individuals with and without schizophrenia, 1987-1996. Schizophrenia Research 55, 277-284. (Pubitemid 34607382)
28. Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V (2001). Mental disorders and cause-specific mortality. British Journal of Psychiatry 179, 498-502.
29. Kato MM, Currier MB, Gomez CM, Hall L, Gonzalez-Blanco M (2004). Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia. Primary Care Companion to the Journal of Clinical Psychiatry 6, 74-77.
30. Koskinen S, Aromaa A (eds.) (2002). Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. National Public Health Institute: Helsinki.
31. Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, Bedogni G (2003). Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Annals of Human Biology 30, 380-391. (Pubitemid 36872480)
32. McElroy SL, Kotwal R, Malhotra S, Nelson EB, Keck PE, Nemeroff CB (2004). Are mood disorders and obesity related? A review for the mental health professional. Journal of Clinical Psychiatry 65, 634-651.
33. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Scott ST, Lieberman JA (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 80, 19-32. (Pubitemid 41587460)
34. McGee DL (2005). Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Annals of Epidemiology 15, 87-97.
35. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004). Actual causes of death in the United States, 2000. Journal of the American Medical Association 291, 1238-1245. (Pubitemid 38541668)
36. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH(1999). The disease burden associated with overweight and obesity. Journal of the American Medical Association 282, 1523-1529. (Pubitemid 29504045)
37. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS, Lieberman JA (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research 86, 15-22.
38. Nilsson BM, Forslund AH, Olsson RM, Hambraeus L, Wiesel FA (2006). Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatrica Scandinavica 114, 27-35. (Pubitemid 43885482)
39. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006). Prevalence of overweight and obesity in the United States, 1999-2004. Journal of the American Medical Association 295, 1549-1555.
40. Osby U, Brandt L, Correia N, Ekbom A, Sparen P (2001). Excess mortality in bipolar and unipolar disorder in Sweden. Archives of General Psychiatry 58, 844-850. (Pubitemid 32979302)
41. Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR, Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004). Pituitary volume in psychosis. British Journal of Psychiatry 185, 5-10.
42. Perälä J, Suvisaari JM, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppä T, Härkänen T, Koskinen S, Lönnqvist J (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 64, 19-28. (Pubitemid 46041735)
43. Pirkola SP, Isometsä E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koskinen S, Aromaa A, Lönnqvist JK (2005). DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population - results from the Health 2000 Study. Social Psychiatry and Psychiatric Epidemiology 40, 1-10.
44. Räikkönen K, Matthews KA, Kuller LH (2007). Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: a comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 30, 872-877. (Pubitemid 46556580)
45. Reaven GM (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
46. Roubenoff R (2003). Sarcopenia: effects on body composition and function. Journals of Gerontology: Biological Sciences and Medical Sciences 58, 1012-1017. (Pubitemid 37467299)
47. Ryan MC, Collins P, Thakore JH (2003). Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. American Journal of Psychiatry 160, 284-289. (Pubitemid 41110453)
48. Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Jarvelin MR, Lauren LH, Savolainen MJ, Koponen HJ (2005). A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. Journal of Clinical Psychiatry 66, 559-563.
49. Salmi JA (2003). Body composition assessment with segmental multifrequency bioimpedance method. Journal of Sports Science and Medicine 2 (Suppl. 3), 1-29.
50. Salmi JA, Pekkarinen H (2004). Segmental assessments of fat-free mass by bioimpedance in relation to DXA. International Journal of Obesity and Related Metabolic Disorders 28, 127.
51. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R (2007). Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Social Psychiatry and Psychiatric Epidemiology 42, 117-124. (Pubitemid 46647112)
52. Sartorio A, Malavolti M, Agosti F, Marinone PG, Caiti O, Battistini N, Bedogni G (2005). Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis. European Journal of Clinical Nutrition 59, 155-160. (Pubitemid 40268311)
53. Satoh M, Sakuda H, Kobayashi T, Kataoka T, Nakao F, Turale S (2007). Comparison of the body fluid levels in healthy individuals and those with schizophrenia in Japan: using the bioelectrical impedance method. Nursing and Health Science 9, 177-184. (Pubitemid 47244181)
54. Susce MT, Villanueva N, Diaz FJ, de Leon J (2005). Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. Journal of Clinical Psychiatry 66, 167-173. (Pubitemid 40314322)
55. Suvisaari JM, Perälä J, Saarni SI, Härkänen T, Pirkola S, Joukamaa M, Koskinen S, Lönnqvist J, Reunanen A (2008). Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. European Archives of Psychiatry and Clinical Neuroscience 258, 129-136. (Pubitemid 351642149)
56. Suvisaari JM, Saarni SI, Perälä J, Suvisaari JVJ, Härkönen T, Lönnqvist J, Reunanen A (2007). Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. Journal of Clinical Psychiatry 66, 1045-1055. (Pubitemid 47340325)
57. Thakore JH (2004). Metabolic disturbance in first-episode schizophrenia. British Journal of Psychiatry 47 (Suppl.), S76-S79.
58. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R (2002). Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. International Journal of Obesity and Related Metabolic Disorders 26, 137-141.
59. Visscher TL, Seidell JC (2001). The public health impact of obesity. Annual Review of Public Health 22, 355-375.